Septerna SEPN
NASDAQ SEPN
$48.06 -4.28 (-8.18%)
As of: Nov 11, 2026 · 11:07 AM EST

Septerna (SEPN) Non-Current Deferred Revenue (2025 - 2026)

Updated

Septerna (SEPN) recorded Non-Current Deffered Revenue of $80.04 million in Q2 2026, down 13.2% from the prior quarter.

Analysis

Septerna (SEPN) Non-Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Septerna reported Non-Current Deffered Revenue of $105.92 million.

  • Per Business Quant, the preceding three quarters came in at $92.18 million (Q1 2026), $105.92 million (Q4 2025) and $120.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Septerna 2.49 Bn 899.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 65.58 Mn
Jun 30, 2026 80.04 Mn
Mar 31, 2026 92.18 Mn
Dec 31, 2025 105.92 Mn
Sep 30, 2025 120.65 Mn
API Access

Septerna Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SEPN&period=max&api_key=YOUR_API_KEY